Search
Powered By HealthLine
Special Offers
Health Tools
 Pregnancy Q&A
 Birth Control Options
 Mom's Diary of the First Weeks
 Baby Due Date Calculator
 Fertilization Summary
Featured Conditions
 Menopause
 Sexual Health
 Breast Cancer
 Skin Care
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Cow's Milk Protein Could Help Save Preemies' Lives


Related Encyclopedia
 border=
Acne
AIDS and HIV Infection
Alagille Syndrome
Amenorrhea
More...

Related Healthscout Videos
 border=
Sports: Play Younger, Play Longer
Fixing Babies' Heads
Removing Tumors Through the Nose
Saving Kids' Eyes: Retinoblastoma
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Absent Father Might Mean Earlier Puberty for Higher-Income Girls
Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure
Most Suicidal Teens Seen in ER Receive Follow-up Care
Kids With Allergies Shouldn't Skip Flu Shots, Experts Say
More...


Page:  << Prev | 1 | 2

The current study included 472 Italian newborns who weighed less than 3.3 pounds (1,500 grams) at birth. Doctors classify these infants as "very low birth weight." Within this category, a baby who weighs less than 2.2 pounds (1,000 grams) at birth, may also be classified as "extremely low birth weight." Generally, such tiny infants are also born prematurely.

The babies were randomly assigned to one of three groups: a control group that received a placebo, a group that was given 100 milligrams (mg) daily of bovine lactoferrin, and a group that was given 100 mg of bovine lactoferrin plus the probiotic Lactobacillus rhamnosus GG. The addition of the probiotic is believed to enhance the antibacterial and antifungal properties of lactoferrin, according to the study. Treatment continued for 30 days with the very low birth weight infants and for 45 days for the extremely low birth weight infants.

The incidence of late-onset (after a baby is 72 hours old) sepsis in the control group was 17.3 percent compared to 5.9 percent in the group receiving lactoferrin. The babies who received lactoferrin plus the probiotic fared best of all, with just 4.6 percent developing sepsis.

Text Continues Below



In his editorial, Kaufman pointed out that the smallest babies had even better results, and suggested that by increasing the dose and length of treatment in the babies who were a little heavier, the results might be even better.

He explained that in these small infants, the lining of the gastrointestinal tract is often underdeveloped, which can allow bacteria to migrate from the digestive system into the bloodstream, causing infection. Lactoferrin helps kill bacteria and fungi, first in the stomach and then in the gastrointestinal tract.

"That makes the mucosal lining barrier stronger and keeps bacteria from moving from the gut into the bloodstream," Kaufman explained.

An added benefit to this treatment, noted Manzoni, is that it could reduce the use of antibiotics as well.

More information

Learn more about infections and other possible complications that can occur in premature infants from the Nemours Foundation.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/6/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Paolo Manzoni, M.D., neonatalogist, S. Anna Hospital, and coordinator, Italian Network for the Study of Neonatal Infections, and, chairman, scientific committee, Neonatalogy Foundation, S. Anna Hospital, Torino, Italy; David Kaufman, M.D., associate professor, pediatrics, assistant medical director, neonatal intensive care unit, and director, the Neonatal Clinical Trials Unit, University of Virginia Medical School, Charlottesville, Va.; Oct. 7, 2009, Journal of the American Medical Association


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy